Monthly Archives: March 2017

Cyteir Therapeutics Presents Preclinical Data Validating RAD51-AID as a Novel Target for Cancer Treatment at American Association of Cancer Research Annual Meeting

2018-03-07T22:46:02+00:00

Cyteir Therapeutics Presents Preclinical Data Validating RAD51-AID as a Novel Target for Cancer Treatment at American Association of Cancer Research Annual Meeting  -- Preclinical data elucidates mechanism and demonstrates successful intervention with small molecules in leukemia and lymphoid cancer models --   -- Clinical candidate expected to be identified in 2017 --  CAMBRIDGE, Mass. – March 28, [...]

Cyteir Therapeutics Presents Preclinical Data Validating RAD51-AID as a Novel Target for Cancer Treatment at American Association of Cancer Research Annual Meeting 2018-03-07T22:46:02+00:00